Trial intelligence / Profile preview

Acmella Oleracea Gel for Analgesia in Digital Rectal Examination

NCT05141864Phase 1Completed

Sponsor
Universidade do Vale do Sapucaí
Start
Mar 2021
Primary completion
Jun 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised, single-blind trial of acmella oleracea in procedural pain (3 arms), sponsored by Universidade do Vale do Sapucaí. Primary endpoint: Visual Analogue Scale for Pain at 1 day. Started Mar 2021; status: completed.

02

Drugs

acmella oleracea
03

Conditions

procedural pain

Beyond the preview

Go deeper on NCT05141864.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05141864.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call